Richard Brown - Chemours Independent Chairman of the Board

CC Stock  USD 26.26  2.62  9.07%   

Chairman

Mr. Richard H. Brown has appointed as Independent Chairman of the Board of the Company with effect on July1, 2015. Mr. Brown has served as Chairman of the Board since July 1, 2015. He currently serves as Chair of Browz, LLC, a global leader of contractor prequalification and compliance solutions since 2005. Formerly, Mr. Brown served as Chair and Chief Executive Officer of Electronic Data Systems from 1999 to 2003. Prior to joining EDS, Mr. Brown served as Chief Executive Officer of Cable Wireless PLC from 1996 to 1999, HR Block Inc. from 1995 to 1996 and Illinois Bell Telephone Company from 1990 to 1995. He is a Trustee Emeritus of the Ohio University Foundation. He previously served on the boards of E. I. du Pont de Nemours and Company from 2001 to 2015, The Home Depot, Inc. from 2000 to 2006, Vivendi Universal from 2000 to 2002, and Seagram Co Ltd. from 1997 to 2000. Mr. Brown also served as a member of the Business Roundtable, the Presidents Advisory Committee on Trade and Policy Negotiations, the U.S.Japan Business Council, the FrenchAmerican Business Council, and the Presidents National Security Telecommunications Advisory Committee. since 2015.
Age 72
Tenure 9 years
Address 1007 Market Street, Wilmington, DE, United States, 19801
Phone302 773 1000
Webhttps://www.chemours.com
Brown has served as Chairman of the Board since the Separation. He currently serves as Chair of Browz, LLC, a global leader of contractor prequalification and compliance solutions since 2005. Formerly, Mr. Brown served as Chair and Chief Executive Officer of Electronic Data Systems from 1999 to 2003. Prior to joining EDS, Mr. Brown served as Chief Executive Officer of Cable & Wireless PLC from 1996 to 1999, H&R Block Inc. from 1995 to 1996 and Illinois Bell Telephone Company from 1990 to 1995. He is a Trustee Emeritus of the Ohio University Foundation.

Chemours Management Efficiency

The current year's Return On Capital Employed is expected to grow to -0.02. The current year's Return On Assets is expected to grow to -0.03. At present, Chemours' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 2.11, whereas Total Assets are forecasted to decline to about 7.5 B. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities.
The company reports 4.24 B of total liabilities with total debt to equity ratio (D/E) of 2.94, which may imply that the company relies heavily on debt financing. Chemours has a current ratio of 1.78, which is generally considered normal. Debt can assist Chemours until it has trouble settling it off, either with new capital or with free cash flow. So, Chemours' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemours sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemours to invest in growth at high rates of return. When we think about Chemours' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

CHAIRMAN Age

Richard NigonNorthern Technologies
70
Neal SchmaleWD 40 Company
71
Richard KelsonIngevity Corp
71
Stephen CroskreyDanimer Scientific
63
Paul NovellyFutureFuel Corp
80
John SchmitzSelect Energy Services
64
Jean BlackwellIngevity Corp
66
Paul IIFutureFuel Corp
80
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6400 people. Chemours Co (CC) is traded on New York Stock Exchange in USA. It is located in 1007 Market Street, Wilmington, DE, United States, 19801 and employs 40 people. Chemours is listed under Diversified Chemicals category by Fama And French industry classification.

Management Performance

Chemours Leadership Team

Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
Dawn Farrell, Independent Chairman of the Board
Curtis Anastasio, Independent Director
Bryan Snell, President - Titanium Technologies
Jonathan Lock, Senior Vice President and Chief Development Officer
Amber Wellman, Chief Officer
Stephen Newlin, Independent Director
Matthew Abbott, Vice President - Digital and Analytics Platforms Leader
David Shelton, Senior Vice President, General Counsel, Secretary
Paul Kirsch, President - Fluoroproducts
Denise Dignam, President - Advanced Performance Materials
Curtis Crawford, Independent Director
Aditya Beri, Interim Business
Mary Cranston, Independent Director
Bradley Bell, Independent Director
Sheryl Telford, Chief Sustainability Officer
Ron Charles, Senior People
Erin Kane, Independent Director
Christian Siemer, President - Chemical Solutions
Alisha Bellezza, President - Thermal & Specialized Solutions
Joseph Martinko, President Solutions
Susan Kelliher, Senior Vice President – Human Resources and Health Services
Gerardo Calderon, President Materials
Eugene Snell, President - Titanium Technologies
Sandra Rogers, Independent Director
Kurt Bonner, Ma Relations
Elizabeth Albright, Sr. VP of HR
Kristine Wellman, General VP
Sean Keohane, Independent Director
Thierry Vanlancker, President of Fluoroproducts
Sameer Ralhan, Chief Financial Officer, Senior Vice President, Treasurer
Guillaume Pepy, Independent Director
Brandon Ontjes, Vice Relations
Camela Wisel, Chief Accounting Officer, Vice President Controller
Mark Newman, Chief Operating Officer, Senior Vice President
Edwin Sparks, President - Chemical Solutions Business, Titanium Technologies
Erich Parker, Senior Vice President of Corporate Communications and Chief Brand Officer.
Mark Vergnano, President, Chief Executive Officer, Director
Lori Ursomarso, IR Contact Officer
Richard Brown, Independent Chairman of the Board
Alvenia Scarborough, Senior Vice President - Corporate Communications and Chief Brand Officer

Chemours Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Chemours

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.

Moving against Chemours Stock

  0.66DNMR Danimer Scientific Financial Report 8th of May 2024 PairCorr
  0.61ASH Ashland Global Holdings Financial Report 7th of May 2024 PairCorr
  0.55NTIC Northern Technologies Report 11th of April 2024 PairCorr
  0.51WTTR Select Energy Services Financial Report 7th of May 2024 PairCorr
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Chemours Stock analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.91)
Earnings Share
(2.00)
Revenue Per Share
40.518
Quarterly Revenue Growth
0.017
Return On Assets
(0.01)
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.